miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN

Jemal, 2011, Global cancer statistics, CA Cancer J Clin, 61, 69, 10.3322/caac.20107

Thorgeirsson, 2002, Molecular pathogenesis of human hepatocellular carcinoma, Nat Genet, 31, 339, 10.1038/ng0802-339

Livraghi, 2011, Treatment options in hepatocellular carcinoma today, Scand J Surg, 100, 22, 10.1177/145749691110000105

Llovet, 2008, Sorafenib in advanced hepatocellular carcinoma, N Engl J Med, 359, 378, 10.1056/NEJMoa0708857

Asghar, 2012, Are there opportunities for chemotherapy in the treatment of hepatocellular cancer?, J Hepatol, 56, 686, 10.1016/j.jhep.2011.07.031

Bartel, 2004, microRNAs: genomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5

Malan-Müller, 2013, Big effects of small RNAs: A review of microRNAs in anxiety, Mol Neurobiol, 47, 726, 10.1007/s12035-012-8374-6

Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702

Manikandan, 2008, Oncomirs: The potential role of non-coding microRNAs in understanding cancer, Bioinformation, 2, 330, 10.6026/97320630002330

Volinia, 2006, A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci USA, 103, 2257, 10.1073/pnas.0510565103

Croce, 2009, Causes and consequences of microRNA dysregulation in cancer, Nat Rev Genet, 10, 704, 10.1038/nrg2634

Kovalchuk, 2008, Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin, Mol Cancer Ther, 7, 2152, 10.1158/1535-7163.MCT-08-0021

Liu, 2014, miR-222 regulates sorafenib resistance and enhances tumorigenicity in hepatocellular carcinoma, Int J oncol, 45, 1537, 10.3892/ijo.2014.2577

Tian, 2015, miR-218 suppresses tumor growth and enhances the chemosensitivity of esophageal squamous cell carcinoma to cisplatin, Oncol Rep, 33, 981, 10.3892/or.2014.3657

Li, 2009, Therapeutic microRNA strategies in human cancer, AAPS J, 11, 747, 10.1208/s12248-009-9145-9

Diakos, 2010, TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a, Blood, 116, 4885, 10.1182/blood-2009-02-206706

Duan, 2010, miR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene, Toxicol In Vitro, 24, 928, 10.1016/j.tiv.2009.11.013

Zhao, 2009, Identification of miRNAs associated with tumorigenesis of retinoblastoma by miRNA microarray analysis, Childs Nerv Syst, 25, 13, 10.1007/s00381-008-0701-x

Asuthkar, 2014, Irradiation-induced angiogenesis is associated with an MMP-9-miR-494-syndecan-1 regulatory loop in medulloblastoma cells, Oncogene, 33, 1922, 10.1038/onc.2013.151

Romano, 2012, miR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through Bim downregulation, Proc Natl Acad Sci USA, 109, 16570, 10.1073/pnas.1207917109

Lim, 2014, MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer, Hepatology, 59, 202, 10.1002/hep.26662

Liu, 2010, Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide, Life Sci, 86, 192, 10.1016/j.lfs.2009.12.002

Sun, 2014, miR-494 is an independent prognostic factor and promotes cell migration and invasion in colorectal cancer by directly targeting PTEN, Int J oncol, 45, 2486, 10.3892/ijo.2014.2665

Esquela-Kerscher, 2006, Oncomirs -microRNAs with a role in cancer, Nat Rev Cancer, 6, 259, 10.1038/nrc1840

Benetatos, 2013, The microRNAs within the DLK1-DIO3 genomic region: Involvement in disease pathogenesis, Cell Mol Life Sci, 70, 795, 10.1007/s00018-012-1080-8

He, 2005, A microRNA polycistron as a potential human oncogene, Nature, 435, 828, 10.1038/nature03552

Ambs, 2008, Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer, Cancer Res, 68, 6162, 10.1158/0008-5472.CAN-08-0144

Shen, 2014, microRNA-494-3p targets CxCR4 to suppress the proliferation, invasion, and migration of prostate cancer, Prostate, 74, 756, 10.1002/pros.22795

Ohdaira, 2012, MicroRNA-494 suppresses cell proliferation and induces senescence in A549 lung cancer cells, Cell Prolif, 45, 32, 10.1111/j.1365-2184.2011.00798.x

Kim, 2011, MicroRNA-494 downregulates KIT and inhibits gastrointestinal stromal tumor cell proliferation, Clin Cancer Res, 17, 7584, 10.1158/1078-0432.CCR-11-0166

Libório-Kimura, 2015, miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer, Oral Oncol, 51, 151, 10.1016/j.oraloncology.2014.11.019

Yamanaka, 2012, Coordinated effects of microRNA-494 induce G2/M arrest in human cholangiocarcinoma, Cell Cycle, 11, 2729, 10.4161/cc.21105

Zhou, 2015, PTEN and hTERT gene expression and the correlation with human hepatocellular carcinoma, Pathol Res Pract, 211, 316, 10.1016/j.prp.2014.11.016

Chalhoub, 2009, PTEN and the Pi3-kinase pathway in cancer, Annu Rev Pathol, 4, 127, 10.1146/annurev.pathol.4.110807.092311

Wang, 2013, The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: A meta-analysis, Curr Med Res Opin, 29, 633, 10.1185/03007995.2013.794775

Ren, 2012, PTEN activation sensitizes breast cancer to PI3-kinase inhibitor through the β-catenin signaling pathway, Oncol Rep, 28, 943, 10.3892/or.2012.1856

Degraffenried, 2004, Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway, Ann Oncol, 15, 1510, 10.1093/annonc/mdh388

Sun, 2015, miR-486 regulates metastasis and chemosensitivity in hepatocellular carcinoma by targeting CLDN10and CITRON, Hepatol Res, 10.1111/hepr.12500

Ohta, 2015, MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A, Oncotarget, 6, 3211, 10.18632/oncotarget.3085

Salvi, 2013, Effects of miR-193a and sorafenib on hepatocellular carcinoma cells, Mol Cancer, 12, 162, 10.1186/1476-4598-12-162

Osaki, 2004, PI3K-Akt pathway: Its functions and alterations in human cancer, Apoptosis, 9, 667, 10.1023/B:APPT.0000045801.15585.dd

Xia, 2013, MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer, Hepatology, 58, 629, 10.1002/hep.26369